[Management of side-effects of targeted therapies in renal cancer: gastrointestinal side-effects].

Author: DavinJean-Louis, DucrottéPhilippe, HouédéNadine

Paper Details 
Original Abstract of the Article :
Several types of gastrointestinal complications can occur during treatment with targeted therapies: diarrhoea, nausea and vomiting, abnormalities in hepatic and pancreatic profiles, etc. Gastrointestinal problems in targeted therapy can have a significant impact on the general status of patients, th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1684/bdc.2011.1445

データ提供:米国国立医学図書館(NLM)

Managing Gastrointestinal Side Effects of Targeted Therapies in Renal Cancer

Targeted therapies are revolutionizing cancer treatment, but they often come with side effects. This study delves into the management of [gastrointestinal side effects] associated with targeted therapies used in [renal cancer]. The researchers provide valuable insights into the types of gastrointestinal complications that can occur, their impact on patient health, and strategies for prevention and treatment.

Gastrointestinal Side Effects: A Common Challenge in Renal Cancer Treatment

Common side effects, such as diarrhea, nausea, and vomiting, can significantly impact patient quality of life and adherence to treatment. The study underscores the importance of early detection and intervention, using medications like [loperamide or racecadotril] to manage diarrhea.

Navigating Side Effects: Ensuring Patient Well-being

This research emphasizes the importance of comprehensive patient care, including careful monitoring and proactive management of gastrointestinal side effects. This approach can help patients optimize treatment outcomes and minimize disruptions to their lives.

Dr.Camel's Conclusion

Just like camels are known for their ability to endure challenging environments, patients undergoing targeted therapies face their own set of challenges. This study provides valuable guidance on navigating these challenges and ensuring patients receive optimal care.

Date :
  1. Date Completed 2015-03-31
  2. Date Revised 2015-03-30
Further Info :

Pubmed ID

25819128

DOI: Digital Object Identifier

10.1684/bdc.2011.1445

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.